• CDC
  • Heart Failure
  • Cardiovascular Clinical Consult
  • Adult Immunization
  • Hepatic Disease
  • Rare Disorders
  • Pediatric Immunization
  • Implementing The Topcon Ocular Telehealth Platform
  • Weight Management
  • Monkeypox
  • Guidelines
  • Men's Health
  • Psychiatry
  • Allergy
  • Nutrition
  • Women's Health
  • Cardiology
  • Substance Use
  • Pediatrics
  • Kidney Disease
  • Genetics
  • Complimentary & Alternative Medicine
  • Dermatology
  • Endocrinology
  • Oral Medicine
  • Otorhinolaryngologic Diseases
  • Pain
  • Gastrointestinal Disorders
  • Geriatrics
  • Infection
  • Musculoskeletal Disorders
  • Obesity
  • Rheumatology
  • Technology
  • Cancer
  • Nephrology
  • Anemia
  • Neurology
  • Pulmonology

2022 CDC Guideline for Prescribing Opioids: A 10-question Quiz

Slideshow

Get up-to-date on the newest guidance for clinicians managing acute, subacute, and chronic pain in adults with this quick quiz.

The US Centers for Disease Control and Prevention (CDC) released new recommendations for clinicians on managing acute (duration of <1 month), subacute (1-3 months), and chronic (>3 months) pain in adults.

The new guidance replaces the CDC Guideline for Prescribing Opioids for Chronic Pain released in 2016, which was interpreted by the health care community as imposing strict opioid dose and duration limits and was misapplied by some organizations, bringing outcry from persons with chronic pain and their advocates and prompting guideline authors to clarify their recommendations in 2019.

Refresh your memory of the CDC Clinical Practice Guideline for Prescribing Opioids for Pain — United States, 2022 with the 10-question quiz below.


Reference: Dowell D, Ragan KR, Jones CM, Baldwin GT, Chou R. CDC Clinical Practice Guideline for Prescribing Opioids for Pain — United States, 2022. MMWR Recomm Rep 2022;71(No. RR-3):1–95. doi: http://dx.doi.org/10.15585/mmwr.rr7103a1

Related Videos
Primary Care is the Answer to the Migraine Care Gap, Says Headache Specialist
© 2024 MJH Life Sciences

All rights reserved.